We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+29.74%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$60.7M
Cap. Flow
+$28.3M
Cap. Flow %
26.83%
Top 10 Hldgs %
81.35%
Holding
68
New
25
Increased
4
Reduced
9
Closed
9

Top Buys

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$17.8M
2
BPMC
Blueprint Medicines
BPMC
+$14.8M
3
GNFT
Genfit
GNFT
+$9.23M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$7.09M
5
EYPT icon
EyePoint Inc
EYPT
+$3.53M

Top Sells

Rank Stock Value
1
MNKD icon
MannKind Corp
MNKD
+$16.2M
2
SCPX
Scorpius Holdings, Inc.
SCPX
+$1.64M
3
IRD
Opus Genetics
IRD
+$1.44M
4
VLRX
VALERITAS HOLDINGS INC
VLRX
+$989K
5
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
+$585K

Sector Composition

Rank Sector Weight
1 Healthcare 68.47%
2 Communication Services 5.16%
3 Technology 1.99%
4 Consumer Discretionary 0.75%
5 Materials 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHIO icon
26
Phio Pharmaceuticals
PHIO
$11.4M
$272K 0.26%
102
+76
+292% +$170K
CRMD icon
27
PUT
CorMedix
CRMD
$564M
$269K 0.25%
+28,500
New +$257K
SHSP
28
DELISTED
SharpSpring, Inc.
SHSP
$242K 0.23%
+15,131
New +$218K
SGLBW
29
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$129K 0.12%
199,836
-500
-0.2% -$343
IMV
30
DELISTED
IMV Inc. Common Shares
IMV
$119K 0.11%
+2,966
New +$144K
NVIV
31
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$116K 0.11%
99
-147
-60% -$171K
RNTX
32
Rein Therapeutics
RNTX
$64.8M
$110K 0.1%
+2,831
New +$88.2K
TRPX
33
DELISTED
Therapix Biosciences Ltd.
TRPX
$98K 0.09%
+31,397
New +$128K
NOVN
34
DELISTED
Novan, Inc. Common Stock
NOVN
$68K 0.06%
7,152
-11,695
-62% -$148K
ICCC icon
35
ImmuCell
ICCC
$99.6M
$64K 0.06%
+10,000
New +$71.4K
GRCE
36
Grace Therapeutics
GRCE
$33.8M
$63K 0.06%
+1,281
New +$63.2K
CHEKZ
37
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$52K 0.05%
136,364
– –
VLRX
38
DELISTED
VALERITAS HOLDINGS INC
VLRX
$35K 0.03%
5,342
-122,521
-96% -$989K
MDGSW
39
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$29K 0.03%
64,286
– –
SHIPW
40
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$27K 0.03%
1,180,400
– –
BVXVW
41
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$25K 0.02%
72,800
– –
NVCN
42
DELISTED
Neovasc Inc.
NVCN
$21K 0.02%
+203
New +$30.4K
IMRNW
43
DELISTED
Immuron Limited Warrants
IMRNW
$15K 0.01%
10,941
– –
FPAYW
44
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$14K 0.01%
50,000
– –
FCEL icon
45
FuelCell Energy
FCEL
$1.45B
$8K 0.01%
+92
New +$15.9K
AMRHW
46
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$8K 0.01%
99,500
– –
ONTXW
47
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$7K 0.01%
132,227
– –
CREXW
48
DELISTED
Creative Realities, Inc. Warrant
CREXW
$6K 0.01%
15,000
– –
BNTCW
49
DELISTED
Benitec Biopharma Limited
BNTCW
$6K 0.01%
50,000
– –
SNGXW
50
DELISTED
Soligenix, Inc. Warrant
SNGXW
$2K ﹤0.01%
16,599
– –
1
2
3

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q1 2019 Portfolio in Review

As of Q1 2019, CVI Holdings held 68 positions worth $106M, up 135% from $44.9M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

CVI Holdings deployed $28.3M of net new capital in Q1 2019, opening 25 new positions and adding to 4 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 42% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was MannKind Corp, an estimated $16.2M trimmed.

  • CVI Holdings's largest Q1 2019 buy was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.
  • CVI Holdings added most to Sio Gene Therapies Inc. Common Stock in Q1 2019, an estimated $7.09M increase.
  • CVI Holdings's biggest Q1 2019 reduction was MannKind Corp, cutting an estimated $16.2M.
  • CVI Holdings fully exited Opus Genetics in Q1 2019, selling an estimated $1.44M.
  • CVI Holdings's ten largest holdings make up 81% of its $106M portfolio in Q1 2019.
  • CVI Holdings opened 25 new positions and closed 9 in Q1 2019.
  • CVI Holdings's portfolio value rose 135% quarter-over-quarter to $106M.

Based on CVI Holdings's 13F filing for Q1 2019, filed 15 May 2019.